Page 23 of 38 · 908 questions tagged peptide-stability.
The specifics, since they change the answer: fibrillation · ecnoglutide · minus 20 °C. I understand the observation; what I do not understand is the mechanism behind…
Stated plainly: dulaglutide · eight weeks · 30 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
Stated plainly: orforglipron · eight weeks · 4 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
The case in front of me: aspartimide formation · tirzepatide · 40 °C. This is one of those things that everyone repeats and nobody derives. This matters practically,…
Conditions: orforglipron · phosphate-buffered diluent. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
The particulars: liraglutide · 2.5 mg/mL. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than discover a problem…
Stated plainly: aggregation · a GLP-1 receptor agonist · 25 °C. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody…
Concretely: ecnoglutide · four weeks · 37 °C. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question…
The specifics, since they change the answer: deamidation · a wide-pore C18 column. I would like the mechanism, because I want to be able to reason about the cases…
What I have: a GLP-1 receptor agonist · six weeks · 37 °C. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like…
Conditions: ecnoglutide · four weeks · 25 °C. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like…
What I am working with: aggregation · 30 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My background…
The case in front of me: survodutide · 8 mg/mL. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision…
Details up front: cagrilintide · 2–8 °C. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence…
Numbers first: 25 °C · retatrutide. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence exists and…
Details up front: a GLP-1 receptor agonist · 25 °C · twenty-eight days. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if…
What I am working with: retatrutide · eight weeks · 37 °C. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not…
I have photographs before and after reconstitution if the visual detail matters. The figures are clear enough; the question is what they mean and what they do not. I…
The case in front of me: ecnoglutide · 20 mg/mL. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one…
Details up front: cagrilintide · six weeks · room temperature. This is a planning question. I know what my options are; I do not know how to weigh them. What I want…
Numbers first: cagrilintide · minus 80 °C. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
Setup, so nobody has to ask: retatrutide · 30 °C · forty-two days. I am trying to build something sustainable rather than something thorough that I will abandon. I…
Stated plainly: dulaglutide · 2–8 °C. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory. What I have…
Stated plainly: orforglipron · 3.33 mg/mL · sixteen weeks. This is asserted often enough that I assumed it was established, and then I went looking for the source. I…